CT volume of enhancement of disease (VED) can predict the early response to treatment and overall survival in patients with advanced HCC treated with sorafenib

Objectives To analyse the predictive value of the volume of enhancement of disease (VED), based on the CT arterial enhancement coefficient (ΔArt%), in the evaluation of the sorafenib response in patients with advanced hepatocellular carcinoma (HCC). Methods Patients with sorafenib-treated advanced H...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European radiology 2021-03, Vol.31 (3), p.1608-1619
Hauptverfasser:	Colagrande, S., Calistri, L., Campani, C., Dragoni, G., Lorini, C., Nardi, C., Castellani, A., Marra, F.
Format:	Artikel
Sprache:	eng
Schlagworte:	Abdomen Aged Antineoplastic Agents - therapeutic use Carcinoma, Hepatocellular - diagnostic imaging Carcinoma, Hepatocellular - drug therapy Computed tomography Diagnostic Radiology Health services Hepatobiliary-Pancreas Hepatocellular carcinoma Humans Imaging Inhibitor drugs Internal Medicine Interventional Radiology Lesions Life Sciences & Biomedicine Liver cancer Liver Neoplasms - diagnostic imaging Liver Neoplasms - drug therapy Male Mathematical analysis Medicine Medicine & Public Health Multivariate analysis Neuroradiology Niacinamide - therapeutic use Parameters Patients Phenylurea Compounds - therapeutic use Radiology Radiology, Nuclear Medicine & Medical Imaging Retrospective Studies Science & Technology Solid tumors Sorafenib - therapeutic use Survival Targeted cancer therapy Tomography, X-Ray Computed Treatment Outcome Tumors Ultrasound
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!